-+ 0.00%
-+ 0.00%
-+ 0.00%

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms

Benzinga·04/26/2025 07:39:55
Listen to the news

On Friday, Cathie Wood-led Ark Invest made several significant trades. The most prominent among these involved the buying and selling of shares in Intellia Therapeutics Inc. (NASDAQ:NTLA), Meta Platforms Inc. (NASDAQ:META), Veracyte Inc. (NASDAQ:VCYT), Symbotic Inc. (NASDAQ:SYM), Baidu Inc. (NASDAQ:BIDU), and UiPath Inc. (NYSE:PATH).

The NTLA Trade: Ark Invest’s ARK Innovation ETF (BATS:ARKK) fund purchased 65,958 shares of Intellia Therapeutics. The shares were bought at a closing price of $8.31, making the total value of the trade approximately $548,136.78. This move comes amidst a 1.59% increase in NTLA’s stock price.

The META Trade: The ARK Autonomous Technology & Robotics ETF (BATS:ARKK) fund sold 1,255 shares of Meta Platforms at a closing price of $547.27. The total value of this sale was approximately $686,324.85. This trade was executed as META’s stock price saw a 2.65% increase.

The VCYT Trade: Ark Invest’s ARKK fund sold 66,135 shares of Veracyte. The shares were sold at a closing price of $32.23, making the total value of the trade approximately $2,131,151.05. This sale was made as VCYT’s stock price experienced a slight increase of 0.28%.

The SYM Trade: ARK Next Generation Internet ETF (BATS:ARKQ) fund bought 8,140 shares of Symbotic at a closing price of $21.93. The total value of this purchase was approximately $178,410.20. This purchase was made despite SYM’s stock price seeing a decrease of 0.59%.

The BIDU Trade: The ARKQ fund also bought 925 shares of Baidu at a closing price of $90.74. The total value of this purchase was approximately $83,934.50. This trade was executed as BIDU’s stock price saw a 1.39% increase.

The PATH Trade: Ark’s ARKW fund sold 984 shares of UiPath at a closing price of $11.59. The total value of this sale was approximately $11,402.56. This sale was made as PATH’s stock price experienced a 2.39% increase.

Read Next:

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo courtesy: Shutterstock